These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7675305)

  • 1. Galanin receptor binding sites in the temporal and occipital cortex are minimally affected in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    Neurosci Lett; 1995 Jun; 192(1):37-40. PubMed ID: 7675305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of [125I]galanin binding sites despite loss of cholinergic neurones to the hippocampus in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    Brain Res; 1991 Dec; 568(1-2):303-6. PubMed ID: 1726069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential alterations of ion channel binding sites in temporal and occipital regions of the cerebral cortex in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    Brain Res; 1993 Dec; 630(1-2):50-6. PubMed ID: 7509712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [125I]galanin binding sites in the rat frontal lobe are guanine nucleotide-sensitive and display a low regional index of occupancy.
    Lagny-Pourmir I; Crépel F
    Neurosci Lett; 1993 Sep; 160(1):29-32. PubMed ID: 8247327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis.
    Mufson EJ; Deecher DC; Basile M; Izenwasse S; Mash DC
    Neuropharmacology; 2000 Jun; 39(8):1404-12. PubMed ID: 10818256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. kappa-1 Opioid receptors of the temporal cortex are preserved in Alzheimer's disease.
    Mackay KB; Dewar D; McCulloch J
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):73-9. PubMed ID: 8579771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and localization of galanin receptors in human entorhinal cortex.
    Deecher DC; Mash DC; Staley JK; Mufson EJ
    Regul Pept; 1998 Feb; 73(3):149-59. PubMed ID: 9556077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin receptors in the post-mortem human brain. Regional distribution of 125I-galanin binding sites using the method of in vitro receptor autoradiography.
    Köhler C; Chan-Palay V
    Neurosci Lett; 1990 Dec; 120(2):179-82. PubMed ID: 1705678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminar and regional distribution of galanin binding sites in cat and monkey visual cortex determined by in vitro receptor autoradiography.
    Rosier AM; Vandesande F; Orban GA
    J Comp Neurol; 1991 Mar; 305(2):264-72. PubMed ID: 1709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease.
    Crawley JN
    Life Sci; 1996; 58(24):2185-99. PubMed ID: 8649205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease.
    Joyce JN; Myers AJ; Gurevich E
    Brain Res; 1998 Feb; 784(1-2):7-17. PubMed ID: 9518532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic mapping of galanin receptors in the monkey brain.
    Köhler C; Hallman H; Melander T; Hökfelt T; Norheim E
    J Chem Neuroanat; 1989; 2(5):269-84. PubMed ID: 2478160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for specific N-terminal galanin fragment binding sites in the rat brain.
    Hedlund PB; Yanaihara N; Fuxe K
    Eur J Pharmacol; 1992 Dec; 224(2-3):203-5. PubMed ID: 1281778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
    Sorbi S; Piacentini S; Amaducci L
    Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis.
    Pérez S; Basile M; Mash DC; Mufson EJ
    J Chem Neuroanat; 2002 Jul; 24(2):109-16. PubMed ID: 12191727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease.
    Martel JC; Alagar R; Robitaille Y; Quirion R
    Brain Res; 1990 Jun; 519(1-2):228-35. PubMed ID: 2168782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat.
    Hedlund P; von Euler G; Fuxe K
    Brain Res; 1991 Sep; 560(1-2):251-9. PubMed ID: 1836971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations.
    Köhler C; Persson A; Melander T; Theodorsson E; Sedvall G; Hökfelt T
    Exp Brain Res; 1989; 75(2):375-80. PubMed ID: 2721615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.